Core Viewpoint - CMB International initiates coverage on China Biopharmaceutical with a "Buy" rating and a target price of HKD 9.4 based on a 10-year DCF model, corresponding to a 2026 adjusted P/E ratio of 37 times [1] Group 1: Company Performance - The company is entering a harvest period for innovative drugs, with rapid growth in biosimilars and stable performance in chemical generics [1] - Currently, the company has received approval for 7 biosimilars, with a total market capacity of RMB 24 billion in sample hospitals for 2024 [1] - The mature sales network in China is expected to facilitate rapid sales growth for biosimilars, particularly for the first generic version of Pertuzumab [1] Group 2: Financial Projections - CMB International forecasts revenue growth of 11.4%, 10.5%, and 9.6% for the years 2025, 2026, and 2027, respectively [1] - Adjusted net profit is projected to grow by 12.2%, 11.5%, and 10.5% for the same years [1] - The current forecasts do not account for potential contributions from several significant innovative products that may receive overseas licensing [1]

Core Viewpoint - The article emphasizes the investment potential in the aviation engine industry, likening it to a "super razor-and-blade" model where initial sales are low-margin, but long-term service and parts replacement generate significant profits [4][16][22]. Group 1: Investment Insights - The aviation engine industry operates under a "triple constraint" where it must achieve high power, low fuel consumption, and extreme reliability simultaneously, making it a unique and challenging sector [10][12]. - The industry is characterized by a long product lifecycle, with significant cash flow generated from after-market services and parts replacement over decades [29][42]. - The market often misprices long-term value due to short-term fluctuations, presenting opportunities for investors who can identify these discrepancies [6][44]. Group 2: Business Model and Competition - The "super razor-and-blade" model in aviation engines involves selling engines at low margins while profiting from high-margin maintenance and parts over time [16][20]. - The CFM56 engine serves as a prime example of this model, showcasing a lengthy development and delivery cycle that creates a substantial technological moat [17][19]. - The aviation engine market is dominated by a few players, and the industry's focus on safety and compliance creates high barriers to entry for new competitors [27][28]. Group 3: Market Dynamics - The aviation industry has recently faced challenges due to supply chain disruptions, impacting the delivery of new aircraft and subsequently increasing demand for after-market services [41][42]. - The industry's reliance on a global supply chain means that any disruption can significantly affect production and service timelines, highlighting the importance of operational resilience [40][41]. - The article notes that while the aviation engine market is currently stable, the long-term outlook remains dependent on technological advancements and the ability to adapt to changing market conditions [37][39].